News

FDA panel debates COVID-19 vaccine recipe as questions swirl about fall shots
Government advisers are convening to discuss potential COVID-19 vaccine updates for the fall and winter, amidst a new policy ...
FDA limits access to COVID-19 vaccine to older adults and other high-risk groups
On May 20, 2025, the Food and Drug Administration announced a new stance on who should receive the COVID-19 vaccine.
STAT1h
Five burning questions on the FDA’s new Covid-19 vaccine framework
Food and Drug Administration Commissioner Marty Makary promised stakeholders last week that the agency’s new Covid-19 vaccine ...
Trump’s FDA just changed COVID vaccine rules for 2025 — will you still qualify for boosters under the new guidelines?
FDA COVID vaccine update is stirring major public attention as a new policy limits fall COVID-19 booster shots to seniors and ...
FDA requires Covid vaccine makers to expand warning about risk of rare heart inflammation
The US Food and Drug Administration will now require Covid-19 vaccines from Pfizer/BioNTech and Moderna to use expanded ...
FDA plans to limit COVID vaccine to only high-risk people: What Oklahomans should know
FDA leaders say the agency will require more clinical trials to show the benefits of annual COVID shots for healthy adults.
FDA won’t approve COVID shot for healthy, non-elderly population
The Food and Drug Administration will no longer approve COVID-19 vaccines for healthy people under 65 without rigorous trials ...
FDA Updates COVID-19 Vaccine Regulations—Here’s What to Know
The FDA has updated COVID-19 vaccine regulations. Only people aged 65 and up, along with certain groups, will be eligible to receive booster shots. FDA officials are asking for more data around the ...
STAT49m
FDA chief pushes back on senators’ criticism, says Covid booster trials should take ‘roughly a year’
The hearing was supposed to focus on the Trump administration’s 2026 budget request, but instead covered a wide range of ...
The New Rational FDA COVID Vaccine Policy is Long Overdue, Says NanoViricides’ Dr. Diwan
SHELTON, CT / ACCESS Newswire / May 22, 2025 / Dr. Anil Diwan, President of NanoViricides, Inc. (NYSE Amer.:NNVC ) (the ...
FDA sets new COVID booster guidelines for healthy adults under 65
The FDA plans to require new clinical trials for approval of annual COVID-19 boosters for healthy Americans under 65.
Health on MSN20h
FDA to Limit Access to COVID Vaccines—What This Means For You
The FDA will now require clinical trials to approve boosters for healthy Americans under 65, making it unlikely the shots ...